Akademik Veri Yönetim Sistemi
Heydarov S., Faydaci Ç. (Yürütücü)
UFUK 2020 Projesi, 2019 - 2020
There are 60 million people with diabetes in the EU (10% of total
population). Diabetes is the major cause of death in the age of 20- 79. Also,
Europe has the highest number of children with Type 1 diabetes (T1D) compared
to other regions with approximately 140,000 diagnosed children and it has
one of the highest prevalence rates of diabetes in children with 21,600 new
cases per year. The frequent glucose monitoring is the key element in achieving
good glycemic control which is the most important factor in preventing diabetes
related complications such as diabetic retinopathy, kidney damage, heart
disease, stroke and etc. Due to the high cost of the current CGM devices or
pain associated with traditional finger-prick measurement, people cannot monitor
their blood glucose level continuously. In 2015, 627,000 people aged between
20-79 died due to diabetes related complications. UK prospective study shows that continuous glucose monitoring leads to
improved glycemic control, which in turn results in reduced diabetes related complications.
Study shows that with continuous glucose monitoring diabetes related
retinopathy and nephropathy (eye damage) in type 1 and type 2 diabetes
decreased around 60% and microvascular complication rate decreased 25%.
Our technology is unique Wristband uses a highly selective and accurate novel polymer technology sensing very low sweat glucose levels which are correlated to blood glucose. Our innovative solution makes the continuous glucose monitoring affordable for all customer segments. The main objectives of this product can be divided into two groups; mainly providing a sustainable healthy lifestyle and reducing the economic burdens., we now aim to introduce our technology to diabetes devices market seeing how our solution offers significant performance improvements and is market disrupting in its potential.